v3.26.3
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 17,912 $ 144,601
Restricted cash 8,000,000 8,000,000
Accounts receivable 2,480,000
Accounts receivable — related party 278,000
Other current assets 78,500 48,500
Current assets of discontinued operations 5,790,758
Total current assets 10,854,412 13,983,859
Digital assets, at fair value 142,423,473 149,885,371
Investment in equity securities, at fair value 252,230
Noncurrent assets of discontinued operations 314,506
Total assets 153,530,115 164,183,736
Current liabilities:    
Accounts payable and accrued expenses 1,620,905 670,765
Contract liability — related party 278,000
Accrued offering costs 500,000 500,000
Advance payable to related party 23,345 12,000
Derivative liability 972,899 1,616,913
Convertible notes, net 9,611,993 7,091,263
Current liabilities of discontinued operations 815,514
Total current liabilities 13,007,142 10,706,455
Noncurrent liabilities of discontinued operations 129,454
Total liabilities 13,007,142 10,835,909
Commitments and contingencies (Note 13)
Shareholders’ equity:    
Series A convertible preferred stock, par value $0.001, 10,000,000 shares authorized; 747,702 shares issued and outstanding as of September 30, 2026 and December 31, 2025 748 748
Common stock, par value $0.001, 100,000,000 shares authorized; 1,847,626 and 1,257,598 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively 1,848 1,258
Common shares to be issued 3,636,262
Additional paid-in capital 168,863,992 163,738,882
Accumulated deficit (31,979,877) (10,393,061)
Total shareholders’ equity 140,522,973 153,347,827
Total liabilities and shareholders’ equity $ 153,530,115 $ 164,183,736